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ABSTRACT
Objectives The coexistence of two complex physiologies 
such as Fontan and pregnancy is still not fully understood. 
We aim to add a unique and essential knowledge to help 
our colleagues in the management of Fontan patients that 
undergo pregnancy as well as the fetus and the placenta 
perfusion.
Methods and results We analyse the coexistence of 
Fontan and pregnancy physiology on a complex case of 
a woman with hypoplastic left heart syndrome palliated 
with a univentricular repair who became pregnant, 
delivered very prematurely and had atypical placental 
findings.
Conclusion Histopathological analysis of the placenta 
could help us to refine the understanding of Fontan 
physiology adaptation during pregnancy, predict women 
and fetal outcomes as well as to plan a better pre- 
pregnancy status. However, further evidence is needed in 
order to reach a more solid and unified conclusion.
INTRODUCTION
An understanding of the interaction between 
pregnancy physiology and Fontan physiology 
is crucial when predicting maternal and fetal 
outcomes for these women embarking on 
pregnancy. Maternal haemodynamic adapta-
tion is limited in women with univentricular 
physiology as they are unable to increase 
cardiac output to meet the increasing 
physiological demands of pregnancy. 
Poor placental health has been previously 
described in patients with a Fontan circula-
tion with increased fibrin deposition being 
the universal histopathological feature.1 
Here we analyse the coexistence of these two 
physiologies in a complex case of a woman 
with hypoplastic left heart syndrome (HLHS) 
palliated with a univentricular repair who 
became pregnant, delivered very prematurely 
and had atypical placental findings.
METHODS
A 23- year- old patient with HLHS and mitral 
atresia and who had undergone a Norwood 
operation and extracardiac Fontan proce-
dure. Her pre- pregnancy weight was 64 kg 
and she had no peripheral oedema. Fetal 
ultrasound confirmed a viable intrauterine 
singleton pregnancy.
A liver fibroscan performed before preg-
nancy showed a stiffness score >17 KPa, 
Key questions
What is already known about this subject?
 ► Unfortunately, no evidence is available regarding 
placentation and its development during pregnancy 
in a patient with univentricular physiology. This in-
teresting investigation describes current challenge 
situations that not only adult congenital heart dis-
ease cardiologists, but also obstetrician and fetal 
specialists presently face in patients with Fontan 
palliation that undergo pregnancy.
What does this study add?
 ► The strengths provided on our manuscript are the 
thorough and multidisciplinary approach that these 
patients warrant throughout their pregnancy as well 
as the importance of the pathological analysis of the 
placenta which is paramount in order to have a bet-
ter physiology understanding and its implications.
How might this impact on clinical practice?
 ► We strongly believe that our manuscript adds a very 
valuable and unique experience and knowledge that 
would definitely be very helpful for our colleagues 
in the management of Fontan patients that under-
go pregnancy as well as the fetus and the placenta 
perfusion.
 ► In the final analysis, the paper creates a paradigm 
for future studies of the evolution of essential 
guidelines and protocols tailored to these subsets 
of patients with a more global understanding of the 
placenta development, its consequences, different 
patterns of presentation and what risk this imposes 
pregnancy to the Fontan palliation.
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indicating Fontan- related hepatic congestion. She also 
had a raised alanine aminotransferase of 125 U/L. She 
was taking warfarin, as is our practice in all Fontan 
patients, and this was changed to full anticoagulation 
dose low molecular weight heparin.
An echocardiogram performed prior to pregnancy 
showed normal single right ventricular (RV) function 
with a tissue Doppler imaging peak systolic wave (TDI 
S’ wave) of 9 cm/s at the base of the anterior RV wall, 
tricuspid annular plane septal excursion (TAPSE) of 
1.9 cm and low velocity venous flow. There was mild atrio-
ventricular (AV) valve regurgitation and no outflow tract 
obstruction.
Cardiac MRI (CMRI) pre- pregnancy showed mildly 
impaired single ventricular (RV) function (ejection frac-
tion 43%), an unobstructed Fontan circuit and mild AV 
valve regurgitation (regurgitant fraction 3%). In addi-
tion, the pulmonary arteries were slightly hypoplastic 
with the left being moreso than the right. Ostial left 
pulmonary artery (LPA) was 8 mm and mid- vessel 9 mm, 
compared with a mid- right pulmonary artery measure-
ment of 13 mm. Pulmonary perfusion was normal and 
there were no signs of flow acceleration at rest.
Routine cardiac catheterisation 4 years prior to preg-
nancy showed unobstructed Fontan pathways with no 
pressure gradients but anatomically mild proximal LPA 
narrowing measuring 8×9 mm compared with 12×10 mm 
distally. Fontan pressure was 12 mm Hg. End- diastolic 
pressure was not measured at that time.
RESULTS
The patient was first seen in the multidisciplinary 
obstetric cardiac clinic at 6 weeks’ gestation. This was her 
first pregnancy.
At that time, she was asymptomatic from a cardiovas-
cular point of view, with an unremarkable clinical exam-
ination: blood pressure (BP) was 110/60 mm Hg, heart 
rate 70 beats/min, oxygen saturations 96% on air, single 
S1 and S2, and a pansystolic murmur loudest at the left 
sternal edge.
During pregnancy, she was seen regularly every 3 weeks 
at our tertiary centre high- risk cardiac antenatal clinic. 
She continued to be well, with oxygen saturations 
94%–96% and BP 110/60–119/75 mm Hg. No clinical 
or electrocardiographic signs of abnormal rhythms were 
noted, nor any symptoms of heart failure.
With relation to fetal well- being, she experienced a self- 
limiting episode of fresh vaginal bleeding at 12 weeks. A 
pregnancy scan at 15 weeks’ gestation showed a large intra-
uterine haematoma/area of haemorrhage, measuring 
59×55×22 mm just superior to the cervix. Fetal growth 
was normal. After discussion with the woman regarding 
risks and benefits, a decision was made to continue with 
full- dose low molecular weight heparin.
At 19, 21 and 24 weeks’ gestation, further fetal ultra-
sound was performed (figure 1). The placenta had an 
abnormal appearance with sonographic features to 
suggest areas of placental infarction. Although fetal 
growth and umbilical artery Dopplers remained normal, 
she was counselled by a fetal medicine specialist that 
such appearances were associated with a high risk of, not 
only fetal growth restriction, but also an acute placental 
event such as a placental abruption and possible in utero 
fetal demise. The maternal echocardiogram at that time 
showed no changes in the function of the single ventricle 
(TAPSE 17 mm and basal anterior RV TDI S’ wave 8 
cm/s) without progression of AV valve regurgitation but 
a mild stenosis at the ostium of the LPA, which had not 
previously been seen on echo, though noted on CMRI. 
Flow in the Fontan circuit was appropriately low velocity.
At week 25, she experienced spontaneous rupture of 
membranes. She presented to hospital 6 hours later in 
advanced labour and spontaneously delivered a female 
infant weighing 700 g (25th centile) who was transferred 
to the neonatal intensive care unit. The baby died at 
6 days of age due to necrotising enterocolitis and extreme 
prematurity.
This mother remained, apart from transient 20–30 min 
of dyspnoea shortly after delivery, cardiovascularly well 
during labour, delivery and the postnatal period with no 
clinical signs or symptoms of infection.
She was discharged on postnatal day 6 with normal 
BP (115/67 mm Hg), no postpartum complications 
and no cardiovascular symptoms. An echocardiogram 
performed on postnatal day 13 revealed progression of 
the AV valve regurgitation to a moderate level, with stable 
single ventricular function, normal Fontan flow and less 
high velocity flow at the ostium of the LPA. The latter 
feature was interpreted as normal in the context of high- 
volume load during pregnancy and post partum.
Figure 1 Fetal ultrasound images at week 19 (A) and 21 (B). 
(A) 2D image showing a dysplastic and enlarged placenta 
with possible fetal growth restriction. (B) Colour image 
showing placental perfusion.
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Placental histology showed maturation of the chorionic 
villi appropriate for the stage of gestation with evidence 
of acute maternal and fetal inflammatory response, chori-
onic vasculitis, funisitis and acute umbilical cord vascu-
litis, involving two out of the three vessels. These findings 
were suggestive of acute chorioamnionitis. In addition 
to this, there was a related area of parabasal infarction 
of chorionic villi with decidual haematoma, presumably 
secondary to placental abruption. There was no increased 
fibrin deposition (figure 2).
DISCUSSION
Fetal outcomes have been reported to be poor in women 
with a Fontan circulation undergoing pregnancy, with 
rates of miscarriage and intrauterine growth restriction 
(IUGR) in excess of 50%, and prematurity in excess 
of 75%.2 An understanding of the complex interplay 
between Fontan physiology, the maternal haemodynamic 
adaptation to pregnancy and impact on fetoplacental 
circulation is pivotal for predicting potential maternal 
and fetal complications in single- ventricle patients.
Fontan completion entails offloading the single 
ventricle and improving oxygenation at the expense of 
a high systemic venous pressure and low cardiac output 
(CO).3 These patients have limited reserve to increase 
their CO to match physiological needs.4 5
During normal pregnancy, there is an increase in stroke 
volume and heart rate, and a decrease in systemic vascular 
resistance. In a Fontan patient, these haemodynamic 
changes are not well tolerated due to the absence of a 
subpulmonary ventricle to pump venous blood into the 
pulmonary circulation and a higher pulmonary vascular 
resistance.3 Therefore, an increase in the systemic venous 
pressure and lower CO secondary to a curtailed preload 
are expected. The impact of the Fontan circulatory 
haemodynamics in pregnancy on placental perfusion is 
inadequately understood. It is possible that the inability 
of the Fontan physiology to augment the stroke volume 
during pregnancy, combined with the increase in systemic 
venous pressure, may lead to placental vascular dysfunc-
tion, hypoperfusion and infarction or abruption.
Fontan- associated liver disease is a well- described 
consequence of the palliated single ventricle circulation 
and occurs as a consequence of chronic venous hyper-
tension.6 As with the liver, the placenta seems to repre-
sent another site of end- organ damage secondary to the 
abnormal haemodynamics of the Fontan and its response 
to the changes in pregnancy.7
Despite literature and clinical experience suggesting 
poor perinatal outcomes, there is a dearth of literature 
on the fetoplacental unit in these women with, to our 
knowledge, only one small case series reported so far.1 
Authors described detailed histology of the placentas 
from 13 deliveries in 7 women with Fontan circulation. 
Only 2 out 13 deliveries were at term with remaining preg-
nancies complicated by pre- eclampsia, preterm rupture 
of membranes, IUGR and placental abruption. Although 
there was wide variation in placental weight and villous 
maturity (likely reflecting range of gestational age of 
delivery), the striking feature common to all placentas 
examined was excessive subchorionic fibrin deposition.1 
Authors speculated that excessive fibrin deposition may 
be due to ‘stagnation of placental blood flow’, namely 
venous stasis secondary to elevated venous resistance, and 
suggested that this could impair placental perfusion. While 
this is an interesting hypothesis, the nature of the study 
design means that selection bias cannot be discounted. 
While perivillous and intervillous fibrin deposition is 
associated with placental dysfunction in conditions such 
as pre- eclampsia and chorionic histiocytic intervillositis, 
subchorionic fibrin deposition is not infrequently seen 
in placentas subjected for routine examination and may 
be a non- specific finding. Moreover, the histological find-
ings reported in our case suggest that poor outcome in 
the absence of excessive subchorionic fibrin deposition 
is possible. It may be that placental venous stasis occurs 
but fibrin deposition does not appear to be a necessary 
finding or event contributing to placental dysfunction in 
this high- risk group of women.
In our patient, evidence of a placental bleed and 
subsequently placental infarcts were apparent on scan 
from early second trimester in spite of relatively stable 
maternal cardiovascular status. Umbilical artery Doppler 
abnormality is an accepted marker of placental insuffi-
ciency. What is surprising in the case presented, is that 
despite sonographic placental findings, both fetal growth 
and umbilical artery Dopplers appeared normal. This is 
in contrast to our previously reported case of poor fetal 
outcome in a woman with good Fontan haemodynamics 
Figure 2 Placenta histology image of the umbilical cord 
showing the chorionic vasculitis (A) and the infarction of the 
chorionic villi (B).
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but whose fetus suffered severe IUGR.8 No placental 
pathology was available but the gross appearances on 
ultrasound were similar to those presented here and in 
the recent Mayo Clinic series.1
The current challenge for those caring for women with 
Fontan is that we have little evidence base from which to 
give individualised advice to prospective mothers, other 
than telling them that pregnancy carries with it a high 
chance of miscarriage or life- changing prematurity. The 
effects of cyanosis are well documented, but we do not 
know the effect of low cardiac output and chronic venous 
hypertension on the growing fetus. Anticoagulation is an 
added and unpredictable additional risk and the benefits 
of it are not well described in the pregnant Fontan, yet it 
significantly increases the risk of bleeding in pregnancy 
and adds to the already elevated fetal risk.9 10 Though 
some centres only fully anticoagulate Fontan patients 
with risk factors, such as an existing right to left shunt, 
reduced ventricular function or history of arrhythmia, it 
is our practice to anticoagulate all of these patients.
In this case it may have resulted in the placental 
bleeding, and does raise the question of whether or not 
full anticoagulation should be reconsidered in these 
women during pregnancy. It may be that antiplatelet 
therapy and/or prophylactic dose low molecular weight 
heparin might be more prudent. There are little data 
on this in the literature as most of the evidence relating 
to anticoagulation in pregnant patients with cardiac 
problems pertains to women with mechanical valves, an 
entirely different cohort of patients.
Fetal loss in the Fontan remains unpredictable. The 
additional challenge also lies in caring for such women in 
a subsequent pregnancy after previous adverse outcome 
when standard maternal, fetal and placental well- being 
surveillance does not predict outcome.
Given the rarity of the condition, there needs to be 
greater international collaboration between cardiologists, 
obstetricians and pathologists to more comprehensively 
study these issues. Setting up registries and databases so 
that these patients can be prospectively studied in order 
to best improve outcomes for mother and baby would 
be an important first step. Additionally, computational 
models of the circulation (including the uterine circu-
lation) hold promise for carrying out parametric studies 
and generate insights into the complex interplay of 
various haemodynamic factors.11 12
CONCLUSION
Placenta pathology analysis should not be overlooked in 
these subsets of patients as it adds essential information 
about the adaptation of the univentricular physiology to 
pregnancy. Further analysis is needed in order to create a 
pre- pregnancy risk stratification score which will help us 
to improve pre- pregnancy clinical status.
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